iShares Trust (IBB)
Management Company · XNAS · Series S000004350 · View on SEC EDGAR ↗
$216.96
As of Aug. 19, 2026
▲ +13.40 (+6.58%)
1-day change
$136.89 – $217.04
52-week range
+0.04%
Premium / Discount
NAV as of Aug. 17, 2026
Feb. 5, 2001
Inception
Net flows (30d): -$29.6M Estimated from creation/redemption of shares outstanding
- Net assets
- $10.1B
- Holdings
- 252
- As of
- Aug. 17, 2026
- Expense ratio
- 0.44% (Moderate)
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Recent changes Positions the fund added, trimmed or exited most recently.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
IBB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of Aug. 19, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +12.28% | — |
| 3M | ▲ +29.77% | — |
| 6M | ▲ +21.73% | — |
| YTD | ▲ +26.25% | — |
| 1Y | ▲ +54.52% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +51.23% | — |
- Volatility 1Y
- 20.88%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- 0.42
- Sharpe 1Y*
- 2.19
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- -$332.0M
- Quarter ending Mar 2026
- -$208.5M
- Trailing 12 months
- +$630.9M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 252 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| 10X GENOMICS CLASS A | TXG | — | — | — | 88025U109 | 0.01675 | EQUITY | USD |
| 4D MOLECULAR THERAPEUTICS INC | FDMT | — | — | — | 35104E100 | 0.006883 | EQUITY | USD |
| AARDVARK THERAPEUTICS | AARD | — | — | — | 002942100 | 0.001864 | EQUITY | USD |
| ABCELLERA BIOLOGICS | ABCL | — | — | — | 00288U106 | 0.03495 | EQUITY | USD |
| ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | — | — | — | 00370M103 | 0.009638 | EQUITY | USD |
| ABSCI CORP | ABSI | — | — | — | 00091E109 | 0.01995 | EQUITY | USD |
| AC IMMUNE SA | ACIU | — | — | — | CH0329023102 | 0.009056 | EQUITY | USD |
| ACADIA PHARMACEUTICALS | ACAD | — | — | — | 004225108 | 0.02508 | EQUITY | USD |
| ACLARIS THERAPEUTICS | ACRS | — | — | — | 00461U105 | 0.01628 | EQUITY | USD |
| ADAPTIVE BIOTECHNOLOGIES | ADPT | — | — | — | 00650F109 | 0.02299 | EQUITY | USD |
| ADC THERAPEUTICS SA | ADCT | — | — | — | CH0499880968 | 0.01399 | EQUITY | USD |
| ADMA BIOLOGICS | ADMA | — | — | — | 000899104 | 0.03345 | EQUITY | USD |
| AGIOS PHARMACEUTICALS | AGIO | — | — | — | 00847X104 | 0.008274 | EQUITY | USD |
| AKERO THERAPEUTICS CVR | AKE | — | — | — | 009CVR044 | 0.01034 | EQUITY | USD |
| AKOUOS CVRS Prvt | — | — | — | 009CVR036 | 0.003148 | EQUITY | USD | |
| ALKERMES | ALKS | — | — | — | IE00B56GVS15 | 0.02422 | EQUITY | USD |
| ALLOGENE THERAPEUTICS | ALLO | — | — | — | 019770106 | 0.03773 | EQUITY | USD |
| ALNYLAM PHARMACEUTICALS | ALNY | — | — | — | 02043Q107 | 0.01976 | EQUITY | USD |
| ALPHA TEKNOVA | TKNO | — | — | — | 02080L102 | 0.001615 | EQUITY | USD |
| ALTIMMUNE INC | ALT | — | — | — | 02155H200 | 0.02711 | EQUITY | USD |
| ALTO NEUROSCIENCE INC | ANRO | — | — | — | 02157Q109 | 0.005231 | EQUITY | USD |
| ALUMIS | ALMS | — | — | — | 022307102 | 0.01243 | EQUITY | USD |
| ALVOTECH SA | ALVO | — | — | — | LU2458332611 | 0.02087 | EQUITY | USD |
| AMGEN INC | AMGN | — | — | — | 031162100 | 0.04121 | EQUITY | USD |
| AMYLYX PHARMACEUTICALS | AMLX | — | — | — | 03237H101 | 0.01378 | EQUITY | USD |
| ANAPTYSBIO | ANAB | — | — | — | 032724106 | 0.004048 | EQUITY | USD |
| ANAVEX LIFE SCIENCES CORP | AVXL | — | — | — | 032797300 | 0.01322 | EQUITY | USD |
| ANNEXON | ANNX | — | — | — | 03589W102 | 0.02143 | EQUITY | USD |
| APOGEE THERAPEUTICS | APGE | — | — | — | 03770N101 | 0.008465 | EQUITY | USD |
| ARBUTUS BIOPHARMA CORP | ABUS | — | — | — | 03879J100 | 0.02357 | EQUITY | USD |
| ARCELLX INC CVR | — | — | — | 039CVR014 | 0.00673 | EQUITY | USD | |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | — | — | — | 03969T109 | 0.003844 | EQUITY | USD |
| ARCUS BIOSCIENCES | RCUS | — | — | — | 03969F109 | 0.01241 | EQUITY | USD |
| ARCUTIS BIOTHERAPEUTICS | ARQT | — | — | — | 03969K108 | 0.01644 | EQUITY | USD |
| ARGENX SE ADR | ARGX | — | — | — | 04016X101 | 0.007723 | EQUITY | USD |
| ARRIVENT BIOPHARMA | AVBP | — | — | — | 04272N102 | 0.004879 | EQUITY | USD |
| ARROWHEAD PHARMACEUTICALS | ARWR | — | — | — | 04280A100 | 0.01967 | EQUITY | USD |
| ARS PHARMACEUTICALS INC | SPRY | — | — | — | 82835W108 | 0.009249 | EQUITY | USD |
| ARVINAS INC | ARVN | — | — | — | 04335A105 | 0.008025 | EQUITY | USD |
| ASCENDIS PHARMA | ASND | — | — | — | DK0060615755 | 0.009191 | EQUITY | USD |
| ATAIBECKLEY INC | ATAI | — | — | — | 04650F101 | 0.04375 | EQUITY | USD |
| ATEA PHARMACEUTICALS | AVIR | — | — | — | 04683R106 | 0.009559 | EQUITY | USD |
| AURA BIOSCIENCES | AURA | — | — | — | 05153U107 | 0.009539 | EQUITY | USD |
| AURINIA PHARMACEUTICALS INC | AUPH | — | — | — | 05156V102 | 0.0169 | EQUITY | USD |
| AUTOLUS THERAPEUTICS ADR PLC | AUTL | — | — | — | 05280R100 | 0.02989 | EQUITY | USD |
| AXSOME THERAPEUTICS | AXSM | — | — | — | 05464T104 | 0.006401 | EQUITY | USD |
| BEAM THERAPEUTICS | BEAM | — | — | — | 07373V105 | 0.01397 | EQUITY | USD |
| BEONE MEDICINES AG | ONC | — | — | — | 07725L102 | 0.01183 | EQUITY | USD |
| BICARA THERAPEUTICS INC | BCAX | — | — | — | 055477103 | 0.005611 | EQUITY | USD |
| BICYCLE THERAPEUTICS ADR PLC | BCYC | — | — | — | 088786108 | 0.005523 | EQUITY | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Page 1
of 6
← Previous
Next →
Sector breakdown
By number of holdings (weight data is not available for this fund's data source).
Healthcare
92.5%
Other/Unmapped
7.5%
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Aug. 17, 2026 | Increased |
AARD — AARDVARK THERAPEUTICS
002942100
|
Units/share: 0.001859 → 0.001864 (0.3%) |
| Aug. 17, 2026 | Increased |
ABCL — ABCELLERA BIOLOGICS
00288U106
|
Units/share: 0.03485 → 0.03495 (0.3%) |
| Aug. 17, 2026 | Increased |
ABSI — ABSCI CORP
00091E109
|
Units/share: 0.01989 → 0.01995 (0.3%) |
| Aug. 17, 2026 | Increased |
ABUS — ARBUTUS BIOPHARMA CORP
03879J100
|
Units/share: 0.0235 → 0.02357 (0.3%) |
| Aug. 17, 2026 | Increased |
ABVX — ABIVAX AMERICAN DEPOSITARY SHARES
00370M103
|
Units/share: 0.009609 → 0.009638 (0.3%) |
| Aug. 17, 2026 | Increased |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
Units/share: 0.02501 → 0.02508 (0.3%) |
| Aug. 17, 2026 | Increased |
ACIU — AC IMMUNE SA
CH0329023102
|
Units/share: 0.009029 → 0.009056 (0.3%) |
| Aug. 17, 2026 | Increased |
ACRS — ACLARIS THERAPEUTICS
00461U105
|
Units/share: 0.01623 → 0.01628 (0.3%) |
| Aug. 17, 2026 | Increased |
ADCT — ADC THERAPEUTICS SA
CH0499880968
|
Units/share: 0.01395 → 0.01399 (0.3%) |
| Aug. 17, 2026 | Increased |
ADMA — ADMA BIOLOGICS
000899104
|
Units/share: 0.03335 → 0.03345 (0.3%) |
| Aug. 17, 2026 | Increased |
ADPT — ADAPTIVE BIOTECHNOLOGIES
00650F109
|
Units/share: 0.02293 → 0.02299 (0.3%) |
| Aug. 17, 2026 | Increased |
ADRO — CHINOOK THERAPEUTICS INC
169CVR016
|
Units/share: 0.006413 → 0.006432 (0.3%) |
| Aug. 17, 2026 | Increased |
AGIO — AGIOS PHARMACEUTICALS
00847X104
|
Units/share: 0.008249 → 0.008274 (0.3%) |
| Aug. 17, 2026 | Increased |
AKE — AKERO THERAPEUTICS CVR
009CVR044
|
Units/share: 0.01031 → 0.01034 (0.3%) |
| Aug. 17, 2026 | Increased |
ALKS — ALKERMES
IE00B56GVS15
|
Units/share: 0.02415 → 0.02422 (0.3%) |
| Aug. 17, 2026 | Increased |
ALLO — ALLOGENE THERAPEUTICS
019770106
|
Units/share: 0.03762 → 0.03773 (0.3%) |
| Aug. 17, 2026 | Increased |
ALMS — ALUMIS
022307102
|
Units/share: 0.01239 → 0.01243 (0.3%) |
| Aug. 17, 2026 | Increased |
ALNY — ALNYLAM PHARMACEUTICALS
02043Q107
|
Units/share: 0.0197 → 0.01976 (0.3%) |
| Aug. 17, 2026 | Increased |
ALT — ALTIMMUNE INC
02155H200
|
Units/share: 0.02703 → 0.02711 (0.3%) |
| Aug. 17, 2026 | Increased |
ALVO — ALVOTECH SA
LU2458332611
|
Units/share: 0.02081 → 0.02087 (0.3%) |
| Aug. 17, 2026 | Increased |
AMGN — AMGEN INC
031162100
|
Units/share: 0.04108 → 0.04121 (0.3%) |
| Aug. 17, 2026 | Increased |
AMLX — AMYLYX PHARMACEUTICALS
03237H101
|
Units/share: 0.01373 → 0.01378 (0.3%) |
| Aug. 17, 2026 | Increased |
ANAB — ANAPTYSBIO
032724106
|
Units/share: 0.004036 → 0.004048 (0.3%) |
| Aug. 17, 2026 | Increased |
ANNX — ANNEXON
03589W102
|
Units/share: 0.02137 → 0.02143 (0.3%) |
| Aug. 17, 2026 | Increased |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
Units/share: 0.005216 → 0.005231 (0.3%) |
| Aug. 17, 2026 | Increased |
APGE — APOGEE THERAPEUTICS
03770N101
|
Units/share: 0.00844 → 0.008465 (0.3%) |
| Aug. 17, 2026 | Increased |
ARCT — ARCTURUS THERAPEUTICS HOLDINGS INC
03969T109
|
Units/share: 0.003833 → 0.003844 (0.3%) |
| Aug. 17, 2026 | Increased |
ARGX — ARGENX SE ADR
04016X101
|
Units/share: 0.0077 → 0.007723 (0.3%) |
| Aug. 17, 2026 | Increased |
ARQT — ARCUTIS BIOTHERAPEUTICS
03969K108
|
Units/share: 0.01639 → 0.01644 (0.3%) |
| Aug. 17, 2026 | Increased |
ARVN — ARVINAS INC
04335A105
|
Units/share: 0.008001 → 0.008025 (0.3%) |
| Aug. 17, 2026 | Increased |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
Units/share: 0.01961 → 0.01967 (0.3%) |
| Aug. 17, 2026 | Increased |
ASND — ASCENDIS PHARMA
DK0060615755
|
Units/share: 0.009163 → 0.009191 (0.3%) |
| Aug. 17, 2026 | Increased |
ATAI — ATAIBECKLEY INC
04650F101
|
Units/share: 0.04362 → 0.04375 (0.3%) |
| Aug. 17, 2026 | Increased |
AUPH — AURINIA PHARMACEUTICALS INC
05156V102
|
Units/share: 0.01685 → 0.0169 (0.3%) |
| Aug. 17, 2026 | Increased |
AURA — AURA BIOSCIENCES
05153U107
|
Units/share: 0.009511 → 0.009539 (0.3%) |
| Aug. 17, 2026 | Increased |
AUTL — AUTOLUS THERAPEUTICS ADR PLC
05280R100
|
Units/share: 0.0298 → 0.02989 (0.3%) |
| Aug. 17, 2026 | Increased |
AVBP — ARRIVENT BIOPHARMA
04272N102
|
Units/share: 0.004864 → 0.004879 (0.3%) |
| Aug. 17, 2026 | Increased |
AVIR — ATEA PHARMACEUTICALS
04683R106
|
Units/share: 0.00953 → 0.009559 (0.3%) |
| Aug. 17, 2026 | Increased |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
Units/share: 0.01318 → 0.01322 (0.3%) |
| Aug. 17, 2026 | Increased |
AXSM — AXSOME THERAPEUTICS
05464T104
|
Units/share: 0.006382 → 0.006401 (0.3%) |
| Aug. 17, 2026 | Increased |
BBIO — BRIDGEBIO PHARMA
10806X102
|
Units/share: 0.02506 → 0.02513 (0.3%) |
| Aug. 17, 2026 | Increased |
BBOT — BRIDGEBIO ONCOLOGY THERAPEUTICS IN
107924102
|
Units/share: 0.006383 → 0.006402 (0.3%) |
| Aug. 17, 2026 | Increased |
BCAX — BICARA THERAPEUTICS INC
055477103
|
Units/share: 0.005594 → 0.005611 (0.3%) |
| Aug. 17, 2026 | Increased |
BCRX — BIOCRYST PHARMACEUTICALS
09058V103
|
Units/share: 0.03189 → 0.03199 (0.3%) |
| Aug. 17, 2026 | Increased |
BCYC — BICYCLE THERAPEUTICS ADR PLC
088786108
|
Units/share: 0.005506 → 0.005523 (0.3%) |
| Aug. 17, 2026 | Increased |
BDTX — BLACK DIAMOND THERAPEUTICS INC
09203E105
|
Units/share: 0.00724 → 0.007262 (0.3%) |
| Aug. 17, 2026 | Increased |
BEAM — BEAM THERAPEUTICS
07373V105
|
Units/share: 0.01392 → 0.01397 (0.3%) |
| Aug. 17, 2026 | Increased |
BHVN — BIOHAVEN
VGG1110E1079
|
Units/share: 0.01857 → 0.01863 (0.3%) |
| Aug. 17, 2026 | Increased |
BIIB — BIOGEN
09062X103
|
Units/share: 0.02169 → 0.02176 (0.3%) |
| Aug. 17, 2026 | Increased |
BIOA — BIOAGE LABS
09077V100
|
Units/share: 0.004659 → 0.004673 (0.3%) |
| Aug. 17, 2026 | Increased |
BMRN — BIOMARIN PHARMACEUTICAL
09061G101
|
Units/share: 0.0282 → 0.02829 (0.3%) |
| Aug. 17, 2026 | Increased |
BNTX — BIONTECH SE ADR
09075V102
|
Units/share: 0.01355 → 0.01359 (0.3%) |
| Aug. 17, 2026 | Increased |
BRKR — BRUKER
116794108
|
Units/share: 0.01646 → 0.01651 (0.3%) |
| Aug. 17, 2026 | Increased |
CABA — CABALETTA BIO
12674W109
|
Units/share: 0.02101 → 0.02107 (0.3%) |
| Aug. 17, 2026 | Increased |
CADL — CANDEL THERAPEUTICS INC
137404109
|
Units/share: 0.008562 → 0.008588 (0.3%) |
| Aug. 17, 2026 | Increased |
CAI — CARIS LIFE SCIENCES
142152107
|
Units/share: 0.01812 → 0.01818 (0.3%) |
| Aug. 17, 2026 | Increased |
CATX — PERSPECTIVE THERAPEUTICS INC
46489V302
|
Units/share: 0.01327 → 0.01331 (0.3%) |
| Aug. 17, 2026 | Increased |
CCCC — C4 THERAPEUTICS
12529R107
|
Units/share: 0.01476 → 0.0148 (0.3%) |
| Aug. 17, 2026 | Increased |
CDNA — CAREDX
14167L103
|
Units/share: 0.006921 → 0.006942 (0.3%) |
| Aug. 17, 2026 | Increased |
CDXS — CODEXIS
192005106
|
Units/share: 0.01238 → 0.01242 (0.3%) |
| Aug. 17, 2026 | Increased |
CGEM — CULLINAN THERAPEUTICS
230031106
|
Units/share: 0.006658 → 0.006678 (0.3%) |
| Aug. 17, 2026 | Increased |
CGON — CG ONCOLOGY
156944100
|
Units/share: 0.008531 → 0.008557 (0.3%) |
| Aug. 17, 2026 | Increased |
CLLS — CELLECTIS ADR REPRESENTING SA
15117K103
|
Units/share: 0.004653 → 0.004667 (0.3%) |
| Aug. 17, 2026 | Increased |
CMPS — COMPASS PATHWAYS ADR PLC
20451W101
|
Units/share: 0.01611 → 0.01615 (0.3%) |
| Aug. 17, 2026 | Increased |
COGT — COGENT BIOSCIENCES
19240Q201
|
Units/share: 0.02178 → 0.02185 (0.3%) |
| Aug. 17, 2026 | Increased |
CRBU — CARIBOU BIOSCIENCES
142038108
|
Units/share: 0.01311 → 0.01315 (0.3%) |
| Aug. 17, 2026 | Increased |
CRGX — CARGO THERAPEUTICS INC
141CVR019
|
Units/share: 0.003958 → 0.00397 (0.3%) |
| Aug. 17, 2026 | Increased |
CRL — CHARLES RIVER LABORATORIES INTERNA
159864107
|
Units/share: 0.007054 → 0.007075 (0.3%) |
| Aug. 17, 2026 | Increased |
CRNX — CRINETICS PHARMACEUTICALS
22663K107
|
Units/share: 0.0145 → 0.01454 (0.3%) |
| Aug. 17, 2026 | Increased |
CRSP — CRISPR THERAPEUTICS AG
CH0334081137
|
Units/share: 0.01329 → 0.01333 (0.3%) |
| Aug. 17, 2026 | Increased |
CRVS — CORVUS PHARMACEUTICALS
221015100
|
Units/share: 0.009426 → 0.009455 (0.3%) |
| Aug. 17, 2026 | Increased |
CSTL — CASTLE BIOSCIENCES
14843C105
|
Units/share: 0.004421 → 0.004434 (0.3%) |
| Aug. 17, 2026 | Increased |
CTKB — CYTEK BIOSCIENCES
23285D109
|
Units/share: 0.01738 → 0.01743 (0.3%) |
| Aug. 17, 2026 | Increased |
CTMX — CYTOMX THERAPEUTICS
23284F105
|
Units/share: 0.02458 → 0.02466 (0.3%) |
| Aug. 17, 2026 | Increased |
CTNM — CONTINEUM THERAPEUTICS INC CLASS A
21217B100
|
Units/share: 0.00428 → 0.004292 (0.3%) |
| Aug. 17, 2026 | Increased |
CYTK — CYTOKINETICS
23282W605
|
Units/share: 0.01766 → 0.01771 (0.3%) |
| Aug. 17, 2026 | Increased |
DFTX — DEFINIUM THERAPEUTICS INC
24477V105
|
Units/share: 0.01887 → 0.01893 (0.3%) |
| Aug. 17, 2026 | Increased |
DNA — GINKGO BIOWORKS HOLDINGS CLASS A
37611X209
|
Units/share: 0.007431 → 0.007453 (0.3%) |
| Aug. 17, 2026 | Increased |
DNLI — DENALI THERAPEUTICS
24823R105
|
Units/share: 0.02208 → 0.02214 (0.3%) |
| Aug. 17, 2026 | Increased |
DSGN — DESIGN THERAPEUTICS
25056L103
|
Units/share: 0.005543 → 0.005559 (0.3%) |
| Aug. 17, 2026 | Increased |
DYN — DYNE THERAPEUTICS
26818M108
|
Units/share: 0.02219 → 0.02226 (0.3%) |
| Aug. 17, 2026 | Increased |
EBS — EMERGENT BIOSOLUTIONS
29089Q105
|
Units/share: 0.007166 → 0.007187 (0.3%) |
| Aug. 17, 2026 | Increased |
EDIT — EDITAS MEDICINE
28106W103
|
Units/share: 0.02089 → 0.02095 (0.3%) |
| Aug. 17, 2026 | Increased |
ELVN — ENLIVEN THERAPEUTICS
29337E102
|
Units/share: 0.008232 → 0.008257 (0.3%) |
| Aug. 17, 2026 | Increased |
ENTA — ENANTA PHARMACEUTICALS INC
29251M106
|
Units/share: 0.004061 → 0.004074 (0.3%) |
| Aug. 17, 2026 | Increased |
ERAS — ERASCA
29479A108
|
Units/share: 0.03088 → 0.03097 (0.3%) |
| Aug. 17, 2026 | Increased |
EWTX — EDGEWISE THERAPEUTICS INC
28036F105
|
Units/share: 0.01165 → 0.01168 (0.3%) |
| Aug. 17, 2026 | Increased |
EXEL — EXELIXIS INC
30161Q104
|
Units/share: 0.0361 → 0.03621 (0.3%) |
| Aug. 17, 2026 | Increased |
FDMT — 4D MOLECULAR THERAPEUTICS INC
35104E100
|
Units/share: 0.006862 → 0.006883 (0.3%) |
| Aug. 17, 2026 | Increased |
FHTX — FOGHORN THERAPEUTICS
344174107
|
Units/share: 0.004626 → 0.00464 (0.3%) |
| Aug. 17, 2026 | Increased |
FLGT — FULGENT GENETICS INC
359664109
|
Units/share: 0.002689 → 0.002697 (0.3%) |
| Aug. 17, 2026 | Increased |
FTRE — FORTREA HOLDINGS INC
34965K107
|
Units/share: 0.01396 → 0.014 (0.3%) |
| Aug. 17, 2026 | Increased |
FULC — FULCRUM THERAPEUTICS
359616109
|
Units/share: 0.008303 → 0.008328 (0.3%) |
| Aug. 17, 2026 | Increased |
GERN — GERON
374163103
|
Units/share: 0.09365 → 0.09393 (0.3%) |
| Aug. 17, 2026 | Increased |
GHRS — GH RESEARCH PLC
IE000GID8VI0
|
Units/share: 0.007215 → 0.007236 (0.3%) |
| Aug. 17, 2026 | Increased |
GILD — GILEAD SCIENCES INC
375558103
|
Units/share: 0.1029 → 0.1032 (0.3%) |
| Aug. 17, 2026 | Increased |
GLUE — MONTE ROSA THERAPEUTICS
61225M102
|
Units/share: 0.008733 → 0.008759 (0.3%) |
| Aug. 17, 2026 | Increased |
GMAB — GENMAB SPONSORED ADR
372303206
|
Units/share: 0.07741 → 0.07764 (0.3%) |
| Aug. 17, 2026 | Increased |
GOSS — GOSSAMER BIO
38341P102
|
Units/share: 0.06626 → 0.06646 (0.3%) |
| Aug. 17, 2026 | Increased |
GPCR — STRUCTURE THERAPEUTICS ADR
86366E106
|
Units/share: 0.008681 → 0.008707 (0.3%) |
| Aug. 17, 2026 | Increased |
GRAL — GRAIL INC
384747101
|
Units/share: 0.005886 → 0.005904 (0.3%) |
| Aug. 17, 2026 | Increased |
GRFS — GRIFOLS ADR REPRESENTING ONE NON-V
398438408
|
Units/share: 0.03267 → 0.03277 (0.3%) |
| Aug. 17, 2026 | Increased |
HALO — HALOZYME THERAPEUTICS
40637H109
|
Units/share: 0.0174 → 0.01745 (0.3%) |
| Aug. 17, 2026 | Increased |
HUMA — HUMACYTE INC
44486Q103
|
Units/share: 0.03622 → 0.03632 (0.3%) |
| Aug. 17, 2026 | Increased |
IBRX — IMMUNITYBIO INC
45256X103
|
Units/share: 0.05585 → 0.05602 (0.3%) |
| Aug. 17, 2026 | Increased |
IDYA — IDEAYA BIOSCIENCES
45166A102
|
Units/share: 0.01233 → 0.01237 (0.3%) |
| Aug. 17, 2026 | Increased |
ILMN — ILLUMINA INC
452327109
|
Units/share: 0.02236 → 0.02243 (0.3%) |
| Aug. 17, 2026 | Increased |
IMCR — IMMUNOCORE HOLDINGS ADR PLC
45258D105
|
Units/share: 0.006297 → 0.006315 (0.3%) |
| Aug. 17, 2026 | Increased |
IMMP — IMMUTEP ADS REPRESENTING LTD
45257L108
|
Units/share: 0.0153 → 0.01534 (0.3%) |
| Aug. 17, 2026 | Increased |
IMRX — IMMUNEERING CLASS A
45254E107
|
Units/share: 0.008474 → 0.008499 (0.3%) |
| Aug. 17, 2026 | Increased |
IMVT — IMMUNOVANT
45258J102
|
Units/share: 0.01202 → 0.01205 (0.3%) |
| Aug. 17, 2026 | Increased |
INBX — INHIBRX BIOSCIENCES INC
45720N103
|
Units/share: 0.001619 → 0.001624 (0.3%) |
| Aug. 17, 2026 | Increased |
INCY — INCYTE CORP
45337C102
|
Units/share: 0.02933 → 0.02942 (0.3%) |
| Aug. 17, 2026 | Increased |
INSM — INSMED INC
457669307
|
Units/share: 0.03182 → 0.03191 (0.3%) |
| Aug. 17, 2026 | Increased |
IONS — IONIS PHARMACEUTICALS
462222100
|
Units/share: 0.02402 → 0.02409 (0.3%) |
| Aug. 17, 2026 | Increased |
IOVA — IOVANCE BIOTHERAPEUTICS INC
462260100
|
Units/share: 0.05757 → 0.05775 (0.3%) |
| Aug. 17, 2026 | Increased |
IRON — DISC MEDICINE
254604101
|
Units/share: 0.004092 → 0.004105 (0.3%) |
| Aug. 17, 2026 | Increased |
IRWD — IRONWOOD PHARMA CLASS A
46333X108
|
Units/share: 0.02329 → 0.02336 (0.3%) |
| Aug. 17, 2026 | Increased |
IXCU6 — E-MINI HEALTH CARE SECTOR SEP 26
Xb8103e27ed0
|
Units/share: 0.0000001793 → 0.0000001804 (0.6%) |
| Aug. 17, 2026 | Increased |
JANX — JANUX THERAPEUTICS
47103J105
|
Units/share: 0.008537 → 0.008563 (0.3%) |
| Aug. 17, 2026 | Increased |
KOD — KODIAK SCIENCES
50015M109
|
Units/share: 0.008562 → 0.008588 (0.3%) |
| Aug. 17, 2026 | Increased |
KROS — KEROS THERAPEUTICS
492327101
|
Units/share: 0.00268 → 0.002688 (0.3%) |
| Aug. 17, 2026 | Increased |
KRYS — KRYSTAL BIOTECH
501147102
|
Units/share: 0.003812 → 0.003824 (0.3%) |
| Aug. 17, 2026 | Increased |
KURA — KURA ONCOLOGY
50127T109
|
Units/share: 0.01281 → 0.01285 (0.3%) |
| Aug. 17, 2026 | Increased |
KYMR — KYMERA THERAPEUTICS
501575104
|
Units/share: 0.01054 → 0.01057 (0.3%) |
| Aug. 17, 2026 | Increased |
KYTX — KYVERNA THERAPEUTICS
501976104
|
Units/share: 0.005552 → 0.005569 (0.3%) |
| Aug. 17, 2026 | Increased |
LAB — STANDARD BIOTOOLS
34385P108
|
Units/share: 0.05525 → 0.05541 (0.3%) |
| Aug. 17, 2026 | Increased |
LCTX — LINEAGE CELL THERAPEUTICS INC
53566P109
|
Units/share: 0.02758 → 0.02766 (0.3%) |
| Aug. 17, 2026 | Increased |
LEGN — LEGEND BIOTECH ADR REP
52490G102
|
Units/share: 0.02194 → 0.02201 (0.3%) |
| Aug. 17, 2026 | Increased |
LENZ — LENZ THERAPEUTICS
52635N103
|
Units/share: 0.004026 → 0.004038 (0.3%) |
| Aug. 17, 2026 | Increased |
LKFT — LAKEFRONT BIOTHERAPEUTICS ADR NV
36315X101
|
Units/share: 0.006166 → 0.006184 (0.3%) |
| Aug. 17, 2026 | Increased |
LRMR — LARIMAR THERAPEUTICS
517125100
|
Units/share: 0.007729 → 0.007752 (0.3%) |
| Aug. 17, 2026 | Increased |
LXEO — LEXEO THERAPEUTICS
52886X107
|
Units/share: 0.009074 → 0.009101 (0.3%) |
| Aug. 17, 2026 | Increased |
LYEL — LYELL IMMUNOPHARMA
55083R203
|
Units/share: 0.001128 → 0.001132 (0.3%) |
| Aug. 17, 2026 | Increased |
MAZE — MAZE THERAPEUTICS
578784100
|
Units/share: 0.005132 → 0.005148 (0.3%) |
| Aug. 17, 2026 | Increased |
MBX — MBX BIOSCIENCES
55287L101
|
Units/share: 0.004371 → 0.004384 (0.3%) |
| Aug. 17, 2026 | Increased |
MDGL — MADRIGAL PHARMACEUTICALS
558868105
|
Units/share: 0.003215 → 0.003225 (0.3%) |
| Aug. 17, 2026 | Increased |
MEDP — MEDPACE HOLDINGS
58506Q109
|
Units/share: 0.00341 → 0.00342 (0.3%) |
| Aug. 17, 2026 | Increased |
MENS — JYONG BIOTECH LTD
KYG831161065
|
Units/share: 0.004281 → 0.004293 (0.3%) |
| Aug. 17, 2026 | Increased |
MESO — MESOBLAST ADR REPRESENTING
590717401
|
Units/share: 0.01044 → 0.01047 (0.3%) |
| Aug. 17, 2026 | Increased |
MGTX — MEIRAGTX HOLDINGS PLC
KYG596651029
|
Units/share: 0.01047 → 0.0105 (0.3%) |
| Aug. 17, 2026 | Increased |
MIRM — MIRUM PHARMACEUTICALS
604749101
|
Units/share: 0.007343 → 0.007365 (0.3%) |
| Aug. 17, 2026 | Increased |
MLYS — MINERALYS THERAPEUTICS
603170101
|
Units/share: 0.008995 → 0.009022 (0.3%) |
| Aug. 17, 2026 | Increased |
MNKD — MANNKIND
56400P706
|
Units/share: 0.0438 → 0.04393 (0.3%) |
| Aug. 17, 2026 | Increased |
MRNA — MODERNA INC
60770K107
|
Units/share: 0.05385 → 0.05401 (0.3%) |
| Aug. 17, 2026 | Increased |
MRVI — MARAVAI LIFESCIENCES HOLDINGS INC
56600D107
|
Units/share: 0.01572 → 0.01577 (0.3%) |
| Aug. 17, 2026 | Increased |
MYGN — MYRIAD GENETICS
62855J104
|
Units/share: 0.01301 → 0.01305 (0.3%) |
| Aug. 17, 2026 | Increased |
NAMS — NEWAMSTERDAM PHARMA
NL00150012L7
|
Units/share: 0.01191 → 0.01194 (0.3%) |
| Aug. 17, 2026 | Increased |
NBIX — NEUROCRINE BIOSCIENCES
64125C109
|
Units/share: 0.01464 → 0.01468 (0.3%) |
| Aug. 17, 2026 | Increased |
NBP — NOVABRIDGE BIOSCIENCES ADR
44975P103
|
Units/share: 0.01234 → 0.01237 (0.3%) |
| Aug. 17, 2026 | Increased |
NGNE — NEUROGENE INC
64135M105
|
Units/share: 0.002348 → 0.002355 (0.3%) |
| Aug. 17, 2026 | Increased |
NMRA — NEUMORA THERAPEUTICS INC
640979100
|
Units/share: 0.01134 → 0.01137 (0.3%) |
| Aug. 17, 2026 | Increased |
NRIX — NURIX THERAPEUTICS INC
67080M103
|
Units/share: 0.0145 → 0.01455 (0.3%) |
| Aug. 17, 2026 | Increased |
NTLA — INTELLIA THERAPEUTICS
45826J105
|
Units/share: 0.01958 → 0.01964 (0.3%) |
| Aug. 17, 2026 | Increased |
NTRA — NATERA
632307104
|
Units/share: 0.02024 → 0.0203 (0.3%) |
| Aug. 17, 2026 | Increased |
NUVB — NUVATION BIO CLASS A
67080N101
|
Units/share: 0.03669 → 0.0368 (0.3%) |
| Aug. 17, 2026 | Increased |
NVAX — NOVAVAX
670002401
|
Units/share: 0.02317 → 0.02324 (0.3%) |
| Aug. 17, 2026 | Increased |
NVCR — NOVOCURE
JE00BYSS4X48
|
Units/share: 0.01546 → 0.0155 (0.3%) |
| Aug. 17, 2026 | Increased |
OABI — OMNIAB INC
68218J103
|
Units/share: 0.01727 → 0.01732 (0.3%) |
| Aug. 17, 2026 | Increased |
OLMA — OLEMA PHARMACEUTICALS
68062P106
|
Units/share: 0.0104 → 0.01043 (0.3%) |
| Aug. 17, 2026 | Increased |
ONC — BEONE MEDICINES AG
07725L102
|
Units/share: 0.0118 → 0.01183 (0.3%) |
| Aug. 17, 2026 | Increased |
OPK — OPKO HEALTH
68375N103
|
Units/share: 0.05551 → 0.05568 (0.3%) |
| Aug. 17, 2026 | Increased |
ORIC — ORIC PHARMACEUTICALS
68622P109
|
Units/share: 0.009158 → 0.009186 (0.3%) |
| Aug. 17, 2026 | Increased |
ORKA — ORUKA THERAPEUTICS INC
687604108
|
Units/share: 0.007514 → 0.007536 (0.3%) |
| Aug. 17, 2026 | Increased |
PACB — PACIFIC BIOSCIENCES OF CALIFORNIA
69404D108
|
Units/share: 0.0429 → 0.04303 (0.3%) |
| Aug. 17, 2026 | Increased |
PCVX — VAXCYTE
92243G108
|
Units/share: 0.02092 → 0.02098 (0.3%) |
| Aug. 17, 2026 | Increased |
PEPG — PEPGEN
713317105
|
Units/share: 0.009355 → 0.009383 (0.3%) |
| Aug. 17, 2026 | Increased |
PGEN — PRECIGEN
74017N105
|
Units/share: 0.0233 → 0.02337 (0.3%) |
| Aug. 17, 2026 | Increased |
PHAT — PHATHOM PHARMACEUTICALS
71722W107
|
Units/share: 0.008373 → 0.008398 (0.3%) |
| Aug. 17, 2026 | Increased |
PHVS — PHARVARIS N V
NL00150005Y4
|
Units/share: 0.004324 → 0.004337 (0.3%) |
| Aug. 17, 2026 | Increased |
PRAX — PRAXIS PRECISION MEDICINES
74006W207
|
Units/share: 0.003868 → 0.00388 (0.3%) |
| Aug. 17, 2026 | Increased |
PRME — PRIME MEDICINE
74168J101
|
Units/share: 0.01398 → 0.01402 (0.3%) |
| Aug. 17, 2026 | Increased |
PRTA — PROTHENA PLC
IE00B91XRN20
|
Units/share: 0.006874 → 0.006895 (0.3%) |
| Aug. 17, 2026 | Increased |
PSNL — PERSONALIS
71535D106
|
Units/share: 0.009238 → 0.009265 (0.3%) |
| Aug. 17, 2026 | Increased |
PTCT — PTC THERAPEUTICS
69366J200
|
Units/share: 0.01187 → 0.0119 (0.3%) |
| Aug. 17, 2026 | Increased |
PTGX — PROTAGONIST THERAPEUTICS
74366E102
|
Units/share: 0.009041 → 0.009068 (0.3%) |
| Aug. 17, 2026 | Increased |
PYXS — PYXIS ONCOLOGY INC
747324101
|
Units/share: 0.007815 → 0.007839 (0.3%) |
| Aug. 17, 2026 | Increased |
QSI — QUANTUM SI INC CLASS A
74765K105
|
Units/share: 0.02499 → 0.02506 (0.3%) |
| Aug. 17, 2026 | Increased |
QTRX — QUANTERIX
74766Q101
|
Units/share: 0.005849 → 0.005867 (0.3%) |
| Aug. 17, 2026 | Increased |
QURE — UNIQURE
NL0010696654
|
Units/share: 0.008397 → 0.008422 (0.3%) |
| Aug. 17, 2026 | Increased |
RAPP — RAPPORT THERAPEUTICS
75383L102
|
Units/share: 0.004231 → 0.004244 (0.3%) |
| Aug. 17, 2026 | Increased |
RARE — ULTRAGENYX PHARMACEUTICAL
90400D108
|
Units/share: 0.01331 → 0.01335 (0.3%) |
| Aug. 17, 2026 | Increased |
RCKT — ROCKET PHARMACEUTICALS
77313F106
|
Units/share: 0.01523 → 0.01528 (0.3%) |
| Aug. 17, 2026 | Increased |
RCUS — ARCUS BIOSCIENCES
03969F109
|
Units/share: 0.01238 → 0.01241 (0.3%) |
| Aug. 17, 2026 | Increased |
REGN — REGENERON PHARMACEUTICALS
75886F107
|
Units/share: 0.01495 → 0.015 (0.3%) |
| Aug. 17, 2026 | Increased |
REPL — REPLIMUNE GROUP
76029N106
|
Units/share: 0.01141 → 0.01145 (0.3%) |
| Aug. 17, 2026 | Increased |
RGEN — REPLIGEN
759916109
|
Units/share: 0.007906 → 0.00793 (0.3%) |
| Aug. 17, 2026 | Increased |
RGNX — REGENXBIO
75901B107
|
Units/share: 0.008715 → 0.008741 (0.3%) |
| Aug. 17, 2026 | Increased |
RIGL — RIGEL PHARMACEUTICALS
766559702
|
Units/share: 0.002676 → 0.002684 (0.3%) |
| Aug. 17, 2026 | Increased |
RLAY — RELAY THERAPEUTICS
75943R102
|
Units/share: 0.02432 → 0.0244 (0.3%) |
| Aug. 17, 2026 | Increased |
ROIV — ROIVANT SCIENCES LTD
BMG762791017
|
Units/share: 0.07652 → 0.07675 (0.3%) |
| Aug. 17, 2026 | Increased |
RVMD — REVOLUTION MEDICINES
76155X100
|
Units/share: 0.02822 → 0.0283 (0.3%) |
| Aug. 17, 2026 | Increased |
RXRX — RECURSION PHARMACEUTICALS CLASS A
75629V104
|
Units/share: 0.06961 → 0.06982 (0.3%) |
| Aug. 17, 2026 | Increased |
RYTM — RHYTHM PHARMACEUTICALS
76243J105
|
Units/share: 0.009831 → 0.009861 (0.3%) |
| Aug. 17, 2026 | Increased |
SANA — SANA BIOTECHNOLOGY INC
799566104
|
Units/share: 0.02663 → 0.02671 (0.3%) |
| Aug. 17, 2026 | Increased |
SEPN — SEPTERNA
81734D104
|
Units/share: 0.004078 → 0.00409 (0.3%) |
| Aug. 17, 2026 | Increased |
SGAFT — CASH COLLATERAL USD SGAFT
Xe4f63973721
|
Units/share: 0.003117 → 0.003126 (0.3%) |
| Aug. 17, 2026 | Increased |
SGMT — SAGIMET BIOSCIENCES SERIES A
786700104
|
Units/share: 0.008621 → 0.008647 (0.3%) |
| Aug. 17, 2026 | Increased |
SION — SIONNA THERAPEUTICS
829401108
|
Units/share: 0.003914 → 0.003926 (0.3%) |
| Aug. 17, 2026 | Increased |
SLDB — SOLID BIOSCIENCES INC
83422E204
|
Units/share: 0.01171 → 0.01175 (0.3%) |
Showing latest 200 of 4992 changes
Institutional owners (13F) 1,036 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| BNP PARIBAS FINANCIAL MARKETS | $421,829,818 | 9.50% | 2,217,939 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $302,042,070 | 6.80% | 1,588,107 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $221,873,575 | 5.00% | 1,166,589 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $213,518,446 | 4.81% | 1,122,659 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $169,085,529 | 3.81% | 889,035 | Shares | June 30, 2026 |
| PEAK6 LLC | $157,876,719 | 3.56% | 830,100 | Call option | June 30, 2026 |
| LPL Financial LLC | $150,135,091 | 3.38% | 789,395 | Shares | June 30, 2026 |
| COMMERCE BANK | $149,648,339 | 3.37% | 786,836 | Shares | June 30, 2026 |
| UBS Group AG | $141,457,236 | 3.19% | 743,768 | Shares | June 30, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $138,077,940 | 3.11% | 726,000 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $127,368,703 | 2.87% | 669,692 | Shares | June 30, 2026 |
| WestEnd Advisors, LLC | $124,744,693 | 2.81% | 655,852 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $100,538,047 | 2.26% | 528,619 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79,613,534 | 1.79% | 418,600 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68,886,818 | 1.55% | 362,200 | Call option | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $66,566,500 | 1.50% | 350,000 | Shares | June 30, 2026 |
| Jefferies Financial Group Inc. | $57,495,733 | 1.29% | 302,306 | Shares | June 30, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | $44,563,427 | 1.00% | 234,310 | Shares | June 30, 2026 |
| BARCLAYS PLC | $38,297,609 | 0.86% | 201,365 | Shares | June 30, 2026 |
| PNC Financial Services Group, Inc. | $38,000,913 | 0.86% | 199,805 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $31,096,065 | 0.70% | 163,500 | Call option | June 30, 2026 |
| STIFEL FINANCIAL CORP | $26,437,159 | 0.60% | 138,996 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $26,214,727 | 0.59% | 137,834 | Shares | June 30, 2026 |
| AMERIPRISE FINANCIAL INC | $24,642,402 | 0.55% | 128,884 | Shares | June 30, 2026 |
| Focus Partners Wealth | $24,013,121 | 0.54% | 126,258 | Shares | June 30, 2026 |
| ALBION FINANCIAL GROUP /UT | $22,753,461 | 0.51% | 119,635 | Shares | June 30, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | $22,083,912 | 0.50% | 116,115 | Shares | June 30, 2026 |
| Cetera Investment Advisers | $22,024,704 | 0.50% | 115,804 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $20,730,710 | 0.47% | 109,000 | Put option | June 30, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $19,368,569 | 0.44% | 101,838 | Shares | June 30, 2026 |
| Itau Unibanco Holding S.A. | $18,805,226 | 0.42% | 98,876 | Shares | June 30, 2026 |
| INVESTMENT HOUSE LLC | $18,394,226 | 0.41% | 96,715 | Shares | June 30, 2026 |
| ExodusPoint Capital Management, LP | $18,265,467 | 0.41% | 96,038 | Shares | June 30, 2026 |
| Erste Asset Management GmbH | $17,342,761 | 0.39% | 102,330 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $16,869,853 | 0.38% | 88,700 | Put option | June 30, 2026 |
| MML INVESTORS SERVICES, LLC | $16,284,678 | 0.37% | 85,623 | Shares | June 30, 2026 |
| ASSETMARK, INC | $16,221,132 | 0.37% | 85,289 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $16,095,532 | 0.36% | 84,570 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $15,614,599 | 0.35% | 82,100 | Call option | June 30, 2026 |
| MAI Capital Management | $15,522,282 | 0.35% | 81,615 | Shares | June 30, 2026 |
| FACTORY MUTUAL INSURANCE CO | $13,503,490 | 0.30% | 71,000 | Shares | June 30, 2026 |
| D. E. Shaw & Co., Inc. | $13,117,594 | 0.30% | 68,971 | Shares | June 30, 2026 |
| Bronte Capital Management Pty Ltd. | $12,515,833 | 0.28% | 65,807 | Shares | June 30, 2026 |
| CUMBERLAND ADVISORS INC | $12,175,583 | 0.27% | 64,018 | Shares | June 30, 2026 |
| NTV Asset Management LLC | $12,169,323 | 0.27% | 63,985 | Shares | June 30, 2026 |
| Beacon Pointe Advisors, LLC | $12,038,493 | 0.27% | 63,297 | Shares | June 30, 2026 |
| Tradition Wealth Management, LLC | $11,826,840 | 0.27% | 62,184 | Shares | June 30, 2026 |
| FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC | $11,607,345 | 0.26% | 61,030 | Shares | June 30, 2026 |
| Horizon Wealth Management, LLC | $11,465,582 | 0.26% | 60,285 | Shares | June 30, 2026 |
| Apella Capital, LLC | $11,404,083 | 0.26% | 57,530 | Shares | June 30, 2026 |
| Corient Private Wealth LP | $10,770,613 | 0.24% | 56,629 | Shares | June 30, 2026 |
| Pictet Asset Management Holding SA | $10,428,961 | 0.23% | 54,950 | Shares | June 30, 2026 |
| Parker Investment Management, LLC | $10,423,041 | 0.23% | 54,803 | Shares | June 30, 2026 |
| BROWN ADVISORY INC | $10,213,796 | 0.23% | 53,703 | Shares | June 30, 2026 |
| CAPITAL FUND MANAGEMENT S.A. | $10,107,647 | 0.23% | 53,145 | Shares | June 30, 2026 |
| Reyes Financial Architecture, Inc. | $10,058,198 | 0.23% | 52,885 | Shares | June 30, 2026 |
| Waverly Advisors, LLC | $9,987,833 | 0.22% | 52,515 | Shares | June 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | $9,884,935 | 0.22% | 51,974 | Shares | June 30, 2026 |
| Sanctuary Advisors, LLC | $9,795,378 | 0.22% | 51,503 | Shares | June 30, 2026 |
| Humankind Investments LLC | $9,509,500 | 0.21% | 50,000 | Shares | June 30, 2026 |
| IFP Advisors, Inc | $9,507,218 | 0.21% | 49,988 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $9,190,076 | 0.21% | 48,321 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $8,991,803 | 0.20% | 47,278 | Shares | June 30, 2026 |
| Kestra Advisory Services, LLC | $8,975,993 | 0.20% | 47,195 | Shares | June 30, 2026 |
| Henshaw Capital LLC | $8,938,930 | 0.20% | 47,000 | Shares | June 30, 2026 |
| L & S Advisors Inc | $8,757,108 | 0.20% | 46,044 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $8,749,554 | 0.20% | 46,004 | Shares | June 30, 2026 |
| DAVENPORT & Co LLC | $8,615,552 | 0.19% | 45,300 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $8,288,262 | 0.19% | 58,200 | Put option | Sept. 30, 2025 |
| FORBES J M & CO LLP | $8,248,730 | 0.19% | 43,371 | Shares | June 30, 2026 |
| DAFNA Capital Management LLC | $8,101,143 | 0.18% | 42,595 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $8,037,702 | 0.18% | 42,261 | Shares | June 30, 2026 |
| SP Asset Management LLC | $7,838,297 | 0.18% | 41,213 | Shares | June 30, 2026 |
| Summit Financial, LLC | $7,552,142 | 0.17% | 39,708 | Shares | June 30, 2026 |
| MMBG INVESTMENT ADVISORS CO. | $7,158,181 | 0.16% | 37,637 | Shares | June 30, 2026 |
| EQUITABLE TRUST CO | $6,731,775 | 0.15% | 35,395 | Shares | June 30, 2026 |
| BEARING POINT CAPITAL, LLC | $6,714,468 | 0.15% | 35,304 | Shares | June 30, 2026 |
| Michelson Medical Research Foundation, Inc. | $6,674,718 | 0.15% | 35,095 | Shares | June 30, 2026 |
| Caption Management, LLC | $6,637,631 | 0.15% | 34,900 | Put option | June 30, 2026 |
| J. Goldman & Co LP | $6,637,631 | 0.15% | 34,900 | Put option | June 30, 2026 |
| Addison Capital Co | $6,542,048 | 0.15% | 34,397 | Shares | June 30, 2026 |
| Williams Jones Wealth Management, LLC. | $6,450,674 | 0.15% | 33,917 | Shares | June 30, 2026 |
| JONES FINANCIAL COMPANIES LLLP | $6,351,704 | 0.14% | 33,901 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $6,166,353 | 0.14% | 43,300 | Call option | Sept. 30, 2025 |
| Equitable Holdings, Inc. | $5,996,315 | 0.14% | 31,528 | Shares | June 30, 2026 |
| Colonial Trust Advisors | $5,970,421 | 0.13% | 31,392 | Shares | June 30, 2026 |
| McCollum Christoferson Group LLC | $5,881,436 | 0.13% | 30,924 | Shares | June 30, 2026 |
| Aristides Capital LLC | $5,782,917 | 0.13% | 30,406 | Shares | June 30, 2026 |
| Y-Intercept (Hong Kong) Ltd | $5,758,953 | 0.13% | 30,280 | Shares | June 30, 2026 |
| Mariner, LLC | $5,618,618 | 0.13% | 29,542 | Shares | June 30, 2026 |
| Volterra Technologies LP | $5,571,996 | 0.13% | 29,297 | Shares | June 30, 2026 |
| Caption Management, LLC | $5,553,548 | 0.13% | 29,200 | Call option | June 30, 2026 |
| SOUTHERN CAPITAL ADVISORS, LLC | $5,517,058 | 0.12% | 29,008 | Shares | June 30, 2026 |
| Howard Capital Management Group, LLC | $5,494,011 | 0.12% | 28,887 | Shares | June 30, 2026 |
| CMH Wealth Management LLC | $5,484,700 | 0.12% | 28,838 | Shares | June 30, 2026 |
| Crescent Grove Advisors, LLC | $5,443,300 | 0.12% | 28,620 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $5,335,590 | 0.12% | 28,054 | Shares | June 30, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $5,334,446 | 0.12% | 29,848 | Shares | June 30, 2026 |
| Gladstone Institutional Advisory LLC | $5,245,758 | 0.12% | 27,582 | Shares | June 30, 2026 |
| FIFTH THIRD BANCORP | $5,221,717 | 0.12% | 27,456 | Shares | June 30, 2026 |
Peer funds
More from this issuer
Similar by size
| Fund | AUM |
|---|---|
| PAAA PGIM ETF Trust | $10.2B |
| EWZ iShares, Inc. | $10.2B |
| IGF iShares Trust | $10.5B |
| VPU VANGUARD WORLD FUND | $10.6B |
| JIRE J.P. Morgan Exchange-Traded Fun… | $10.6B |
| DFCF Dimensional ETF Trust | $10.1B |
| SCHH SCHWAB STRATEGIC TRUST | $10.0B |
| BUFR First Trust Exchange-Traded Fun… | $9.6B |
| FNDE SCHWAB STRATEGIC TRUST | $9.6B |
| PRF Invesco Exchange-Traded Fund Tr… | $9.5B |